Abdulrazzak Zarifa

Statistics

Publications

Citations

358

H-Index

Active since

2019

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

Texas Children's Hospital

Abdulrazzak Zarifa is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2019–2023

Publications

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma

Mouhammed Amir Habra, Bettzy Stephen, Matthew T. Campbell et al. · Journal for ImmunoTherapy of Cancer · 2019 · 154 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract

Michael Frumovitz, Shannon N. Westin, Gloria Salvo et al. · Gynecologic Oncology · 2020 · 70 citations · Full text

Medicine, Oncology, Pharmacology +13

Associations between the gut microbiome and fatigue in cancer patients

Joud Hajjar, Tito R. Mendoza, Liangliang Zhang et al. · Scientific Reports · 2021 · 45 citations · Full text

Life Sciences, Microbiology, Oncology +17

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience

Mehmet Altan, Felipe Soto, Linda Zhong et al. · The Oncologist · 2023 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory

Tito R. Mendoza, Ajay Sheshadri, Mehmet Altan et al. · Journal for ImmunoTherapy of Cancer · 2020 · 21 citations · Full text

Nursing, Immunology, Oncology +17

1–5 of 8